According to Fuji Pharma latest financial reports the cash on hand of 4554 is $16.29M, an decrease of -34.46% to 2022. At the end of 2022 company had $24.86M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $16.29M | -34.46% |
2022 | $24.86M | -65.23% |
2021 | $71.49M | -15.30% |
2020 | $84.41M | 41.76% |
2019 | $59.54M | 35.88% |
2018 | $43.82M | - |